Clinical Trial Update: Extended Delivery of Bupivacaine Study in Herniorrhaphy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating extended delivery of bupivacaine for analgesia in herniorrhaphy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia

Drugs mentioned

• Extended-delivery bupivacaine (bupivacaine)

Snippet

Sponsor: Heron Therapeutics | Conditions: Analgesia | Phase 4 | Status: COMPLETED